The Southern Hemisphere’s first cell-based vaccine manufacturing facility has opened in Tullamarine. The new CSL Seqirus facility will be able to supply Australia with critical health products, including pandemic and seasonal influenza vaccines, lifesaving antivenoms and Q-Fever vaccines. The $1 billion, ten-year agreement between the…
